Clinical Trial

Real-World Effectiveness of Tezepelumab in Allergic Bronchopulmonary Aspergillosis

Name: Real-World Effectiveness of Tezepelumab in Allergic Bronchopulmonary Aspergillosis — clinical trial record (NCT07757841)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

An open-label study will evaluate effects of Tezepelumab in the treatment of severe asthma in patients with allergic bronchopulmonary aspergillosis

Trial Details

NCT Number	NCT07757841
Lead Sponsor	Qianfoshan Hospital
Conditions	Allergic Bronchopulmonary Aspergillosis, Severe Asthma, ABPA
Enrollment	10 participants
Start Date	2026-09-01
Primary Completion	2027-06-30 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-11